Internal Communications

By Chris Bath, Managing Director at Aurora Healthcare Communications

The world is in shock.

Pandemic ‘recovery’; cost of living crisis; rising inflation and geopolitical instability at an all-time high for a generation. We’re in the middle of a polycrisis, and that’s not all.

Around 1.5 billion people will be going to the polls this year, as significant elections are taking place in more than 50 countries which between them hold almost half of the world’s population. 

Uncertainty, then, is a constant we have come to live with. The result of this, is that we have come to crave something many people shy away from: change.

Global change coming to life science is good for all.

The life science industry, often proving to be resistant to most existential crises and pressure, has faced unprecedented low levels of investment, M&A activity and, as a result, lagging clinical pipelines. 2023 saw the lowest number of clinical trial starts since 2018.

If the world is in shock, the industry needs a shock of its own to ignite the change that innovation needs. This change is round the corner.

‘Pipeline in a product’ therapeutics, along with new and complex modalities, that will transform medicine, and, if given the right access environment, will also necessitate a reset, or change, in how we treat disease. Countries are rapidly standing up modern health systems that can accommodate these new innovations (let’s park capacity for a second, because that’s an altogether different challenge) and this rapid expansion requires genuine global expertise.

According to Deloitte, one of the main reasons why larger biopharma organisations miss their growth targets is because of an inadequate understanding of market dynamics and a complete misunderstanding of customer needs. A shameful finding given the hyperconnected world we live in. In today’s world, there really is no excuse, and change is not being embraced to stay in sync with the world today.

A true worldview and ‘global’ expertise then are paramount. But there really is no such thing as ‘global’ when it comes to life sciences. With every border comes a new culture to embrace, a new set of compliance considerations to consider and a new health system to navigate. The reality is that our work needs to resonate with countries and regions far more diverse than the term ‘Global’ allows.

For global strategy to be a success, you need to think ‘Glocally.’

Overcoming tunnel vision by thinking ‘Glocal’

How we tell stories about breakthrough science and the value this delivers to countries with unmet needs, demands a worldview on a range of issues to make sure medicine gets into the hands of those who need it.

Recent changes to EU regulations (for example, the Clinical Trial Regulation and new Medical Device/IVD Regulation) and other market uncertainties, such as cross-border collaborations and their potential impact on market access, are making it increasingly difficult for biopharma and biotech to forge ahead.

For programmes to resonate (and results to follow), multiculture, diversity and the need to consider all stakeholders in the care pathway are important, and that requires more than just a local presence, it necessitates a true understanding of local market dynamics. That means:

• Ensuring clinical trial recruitment materials are trans-created, so they not only resonate in-market, but also, they engage sites and recruit patients, and protocols co-designed with patient experience data.
• Commercial strategies are built with worldwide insight, supporting activities designed to drive uptake of medicines and new technologies through creative-led medical communications.
• Market access plans need to be shaped with payors years in advance of a commercial launch, and the right data generated through clinical development programs to gain reimbursement.
• Building global integrated teams that deliver across time zones to deliver at pace with cultural and compliance understanding built in.

As innovation lays a path for companies to expand internationally, we need to re-calibrate our understanding of the needs of nations and regions and people in a way that demands genuine expertise.

Our clients need partners who understand all these challenges, and in fact are purposefully designed to address and embrace them. So, that’s what we’ve built.

A Global vision with local precision

With decades of experience across every region of the globe, we’ve witnessed firsthand how the nuances of local geographies and cultures influence each phase of drug development and commercialisation. These insights have shaped our approach, leading us to create a platform of services that operate in harmony across the globe, delivering results that are truly greater than the sum of their parts.

By integrating solutions from clinical trial enrollment and medical communications to consulting and advertising, we’ve created an ability to take a wide-angle view, offering comprehensive, end-to-end support that spans the entire lifecycle—from early clinical milestones through to launch and global expansion.

This strategic offering is deeply ingrained in our heritage and our long-standing commitment to Global Health Marketing and Communications (GHMC)—the world’s largest network of independent healthcare agencies. Together, we’ve seen the difference a strategic and sensitive approach to multi-market programmes can make, as part of a deep understanding of healthcare across markets, cultures and codes.

As we seek to deliver change, we need to embrace it. And that’s what a truly ‘global’ partner like Spectrum Science is designed to do. If you want to see what this difference looks like, get in touch.

By Kaitlin Bowen and Mark Henderson

Recently, partners from around the world gathered to learn, share and connect during the 2017 GLOBALHealthPR^® (GHPR) Annual General Meeting, held in Mexico City. One of the unique aspects we discussed in Mexico is the annual GHPR employee exchange program. We recently interviewed the participants of this year’s program to reflect on the highlights:

 As a part of the GLOBALHealthPR (GHPR) exchange program, Mark Henderson from VIVA! Communications in Australia and Kaitlin Bowen from Spectrum in the United States flew halfway around the world to “swap desks” and experience healthcare communications in each other’s home countries.

The exchange program, designed to enhance the connectivity of GHPR agencies, helps foster collaboration among the independent health and science communications network and enables agency employees the opportunity to gain insight into the drivers that affect health and science communications in other markets.

Kaitlin and Mark reflected recently on the major differences between the two countries and what they gained from their GLOBALHealthPR exchange experience.

What is the major difference you saw between the health industries in Australia and the United States?

Mark Henderson – VIVA! Communications, Australia: While in the States, I learned about medicines when I wasn’t even expecting to, as direct-to-consumer (DTC) advertisements often appeared on television and in magazines – this came as quite a surprise to me. I was enthralled by the advertising, but further to this, the amount of political discussion and conversation in the community around healthcare and medicines. That was intriguing, and I think it’s a good thing.

Living in Australia, we tend to become complacent about our access to free medicines and hospital care (well, free for the most part), and that shrinks the public conversation on healthcare in Australia somewhat. That is, unless one is championing a certain medicinal cause, working in the health industry or battling with a disease that requires difficult to access therapies.

On a slightly different note, I was shocked to see promotion of cigarettes in the U.S. I picked up a magazine at the airport, and was confronted with a discount offer for a new brand of cigarettes. Not just an advertisement, but a discount offer for cigarettes – how can this be allowed?

In Australia, we have so many regulations regarding cigarette advertising in attempts to decrease cancer rates –our laws include plain packaging, locked cabinets and no advertisements for cigarettes. So to see cigarettes advertised in the U.S. was confronting.

Kaitlin Bowen – Spectrum, United States: Due to the restrictions around direct-to-consumer advertising in Australia via the Medicines Australia Code of Conduct, healthcare companies and the PR and marketing agencies that support them must be creative to connect with stakeholders in meaningful ways. Empowering advocacy partners and patients is critical.

Due to this tightly regulated health communications environment, VIVA!’s work tends to be highly patient-centric, which is great. Most campaigns include regional or state-specific patient spokespeople who can provide first-hand commentary on what it’s like to live with a certain disease or condition. This, combined with dynamic content and a the knack for media relations creates  comprehensive patient case studies, videos and infographics (both still and animated) that are really easy for the media to reference and extract for use in their stories.

How does the working culture differ between VIVA! & Spectrum?

KB, USA:  Overall, the team is very collaborative and it’s often all hands on deck to do great work for our clients. Even the agency’s Principal is not afraid to jump in and help, lending her expertise and experience to all aspects of client service, including making pitch calls and proofing content.

Additionally, I found Australians to be quite direct with each other – no sugar coating feedback or direction – which helps keep projects moving along efficiently. I think it also helps boost camaraderie within the agency, which can go a long way for maintaining morale among employees and ultimately helps drive a better quality product for clients.

The VIVA! office had a similar vibe to our Spectrum offices with lots of open, collaborative space and cool, scientific imagery around the office.

I view my Spectrum team as family, so I think the VIVA! gang is pretty much our cousins Down Under – the people, culture and energy in the office space were surprisingly similar to our Spectrum team here in the U.S. That’s the great part about the GLOBALHealthPR network – the agencies are so like-minded not only in our office environments, but also in our values and what motivates us to do great work for our clients.   I feel so fortunate to have had the opportunity to live, work and play in Sydney for a few weeks and form long-lasting friendships with our GLOBALHealthPR partners in Australia.

 MH, AUS: Overall, both Spectrum and VIVA! work in the highly specialised healthcare PR arena, part of which allows us to craft and share the fascinating stories that create buzz and hype around healthcare therapies, medicines, medical research and science.

I was really privileged to meet so many American healthcare PR peers, and was impressed by the different stories and reasons for pursuing healthcare communications. Some of the Spectrum staff have Ph.D.’s and are trained scientists. The knowledge and experience that these experts can lend to the science of health is invaluable, and they are lovely people too!

How will you continue to build relationships across the GLOBALHealthPR network now that you’re back home?

 MH, AUS: I think the amazing thing about the exchange program is that we are visiting and partnering with not just friends, but colleagues. I’m thrilled to be able to have the opportunity to continue to grow and build relationships with all of my healthcare PR peers. It’s something truly unique to GLOBALHealthPR.

I am eager to remain in touch, and to continue working alongside and collaborating with my American counterparts, and friends in the U.S.

KB, USA: In the words of Uncle Ben from Spiderman, “with great power comes great responsibility.” Because I’ve been given the amazing privilege to participate in the GHPR exchange program, I believe it’s important as partners that we continue to support and build the GLOBALHealthPR network on behalf of each of our agencies.

The beauty of GHPR is that each of us are experts in our local healthcare marketplaces, but we have that global reach and connectivity across the world through each partner agency. What’s really special is that we’re not just professional acquaintances, but friends. I remain connected to my VIVA! colleagues on Facebook and always look forward to hearing the latest client updates and the GHPR Annual General Meeting. In the spirit of the GHPR exchange program, I will continue to work to foster collaboration and best practice sharing across the network.

Kaitlin Bowen is an Account Director at GHPR U.S. partner Spectrum. Mark Henderson is the Queensland Branch Manager at GHPR Australian partner VIVA! Communications. To check out Kaitlin’s and Mark’s experiences from the GLOBALHealthPR Professional Exchange Program and other GHPR programming, use #GHPRConnects to connect and join the conversation.

 

Arriving in New York City on Sunday, I was immediately taken aback by the sheer size and volume of the place. It is a phenomenal city to behold.

I was met and given a tour of the new office space, in Battery Park, close to the most southernmost tip of Manhattan Island and located on the 26th floor of a skyscraper, by Senior Vice President, GLOBALHealthPR at Spectrum, Tim Goddard.

Tim gave me a tour of the very sleek, modern office, which offers a magnificent view over Battery Park, while also offering the chance to see the Statue of Liberty from the office balcony.

Leaving the office, Tim took me to visit the 9/11 memorial pools, and museum, which, although a somewhat heavy experience, allowed me to get a real insight into how that tragedy has shaped the New York City of today.

On Monday, I spent my first day in New York office, and was privileged to meet with many of the team, as well, as allowing me to participate in the BioPharma Monthly Team meeting, and to discover lots about the different brands and companies that the BioPharma team works with in the USA.

And, later in the day, I had a phone call to discuss the Consumer Science Practice with Senior Vice President, Darby Pearson. Unlike much of the biotech and pharma-specific work done by Spectrum, the Consumer Science Practice focuses on telling the scientific story of certain consumer products.

This was very interesting to discuss with Darby, and, I was able to offer my feedback and insight around some of the campaign ideas and suggestions that her team is working on, which was a real privilege.

Although the day flew in, it was fascinating to see the New York Office as it came to life, and it’s been really nice to get to meet with some of the team. I look forward to what the rest of the week has in store.

Mark is participating in the GLOBALHealthPR Professional Exchange Program representing exclusive Australian partner, VIVA! Communications. The Program aims to enhance the connectivity of GLOBALHealthPR agencies through collaboration, best practice sharing, and insights into the drivers that affect health and science communications in different markets worldwide, and to build professional relationships with other GLOBALHealthPR personnel around the globe.

About Mark: Mark Henderson is Queensland Branch Manager at GHPR Australia partner, VIVA! Communications. To follow his experiences on the GLOBALHealthPR Professional Exchange Program online, use #GHPRConnects to join the conversation and follow all of the 2016 exchange programming.

Today´s blog comes to us from our GLOBALHealthPR partner in Germany, fischerAppelt. 

The reasons and motives for internal communication are as diverse as their possible outcomes. This is especially true in global healthcare organizations, where messages considered clear and straightforward in one region might not be understood the same way in another. For this reason, implementing effective internal communications strategies across multiple locations is crucial. [Read more…] about Internal Communication in Healthcare: Speak and Let Speak